HWAM
CORT icon

Hennion & Walsh Asset Management’s Corcept Therapeutics CORT Stock Holding History

Hennion & Walsh Asset Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.95M Sell
45,429
-550
-1% -$33.2K 0.11% 233
2026
Q1 		$1.85M Sell
45,979
-10,967
-19% -$410K 0.06% 366
2025
Q4 		$1.98M Buy
56,946
+605
+1% +$47.5K 0.07% 349
2025
Q3 		$4.68M Buy
56,341
+7,850
+16% +$568K 0.17% 148
2025
Q2 		$3.56M Buy
48,491
+2,342
+5% +$170K 0.14% 177
2025
Q1 		$5.27M Sell
46,149
-1,973
-4% -$120K 0.23% 89
2024
Q4 		$2.42M Sell
48,122
-21,205
-31% -$1.11M 0.11% 241
2024
Q3 		$3.21M Buy
69,327
+9,838
+17% +$350K 0.15% 180
2024
Q2 		$1.93M Buy
59,489
+4,620
+8% +$127K 0.1% 255
2024
Q1 		$1.38M Buy
54,869
+15,335
+39% +$362K 0.07% 339
2023
Q4 		$1.28M Sell
39,534
-573
-1% -$15.7K 0.07% 347
2023
Q3 		$1.09M Buy
40,107
+6,756
+20% +$196K 0.07% 340
2023
Q2 		$742K Buy
33,351
+3,406
+11% +$78.4K 0.04% 428
2023
Q1 		$649K Buy
29,945
+9,851
+49% +$216K 0.04% 448
2022
Q4 		$408K Buy
+20,094
New +$504K 0.03% 541
2021
Q2 		– Sell
-10,771
Closed -$256K – 731
2021
Q1 		$256K Buy
+10,771
New +$288K 0.02% 632

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hennion & Walsh Asset Management's CORT Position: Q2 2026 in Review

Hennion & Walsh Asset Management reduced its Corcept Therapeutics (CORT) stake by 1.2% in Q2 2026, selling an estimated $33.2K and leaving 45,429 shares worth $3.95M. The position accounts for 0.11% of the portfolio, ranked #233.

Hennion & Walsh Asset Management first reported a position in CORT in Q1 2021 and has held it in 16 quarters since. The position peaked at $5.27M in Q1 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Hennion & Walsh Asset Management held 45,429 shares of Corcept Therapeutics worth $3.95M as of Q2 2026.
  • Hennion & Walsh Asset Management sold 550 Corcept Therapeutics shares in Q2 2026, an estimated $33.2K.
  • Corcept Therapeutics made up 0.11% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #233 holding.
  • Hennion & Walsh Asset Management first reported a position in Corcept Therapeutics in Q1 2021 and has held it in 16 quarters since.
  • Hennion & Walsh Asset Management's Corcept Therapeutics position peaked at $5.27M in Q1 2025.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.